Correlation Between Larimar Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Candel Therapeutics.
Diversification Opportunities for Larimar Therapeutics and Candel Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Larimar and Candel is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Larimar Therapeutics is 1.05 times less risky than Candel Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 519.00 in Candel Therapeutics on September 5, 2024 and sell it today you would lose (68.00) from holding Candel Therapeutics or give up 13.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Candel Therapeutics
Performance |
| Timeline |
| Larimar Therapeutics |
| Candel Therapeutics |
Larimar Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Candel Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Larimar Therapeutics vs. Candel Therapeutics | Larimar Therapeutics vs. Cingulate Warrants | Larimar Therapeutics vs. Unicycive Therapeutics | Larimar Therapeutics vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |